Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 3/10

vs
industry
vs
history
Cash to Debt 0.11
UNIS's Cash to Debt is ranked lower than
53% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.04 vs. UNIS: 0.11 )
UNIS' s 10-Year Cash to Debt Range
Min: 0.07   Max: No Debt
Current: 0.11

Equity to Asset -0.23
UNIS's Equity to Asset is ranked lower than
53% of the 301 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.58 vs. UNIS: -0.23 )
UNIS' s 10-Year Equity to Asset Range
Min: -0.23   Max: 0.79
Current: -0.23

-0.23
0.79
F-Score: 4
Z-Score: -4.87
M-Score: -3.35
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -436.70
UNIS's Operating margin (%) is ranked lower than
55% of the 308 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.92 vs. UNIS: -436.70 )
UNIS' s 10-Year Operating margin (%) Range
Min: -2225.96   Max: -1.77
Current: -436.7

-2225.96
-1.77
Net-margin (%) -489.54
UNIS's Net-margin (%) is ranked lower than
55% of the 308 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.28 vs. UNIS: -489.54 )
UNIS' s 10-Year Net-margin (%) Range
Min: -2303.97   Max: -2.59
Current: -489.54

-2303.97
-2.59
ROE (%) -1212.39
UNIS's ROE (%) is ranked lower than
57% of the 297 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.57 vs. UNIS: -1212.39 )
UNIS' s 10-Year ROE (%) Range
Min: -277.5   Max: -3.54
Current: -1212.39

-277.5
-3.54
ROA (%) -86.21
UNIS's ROA (%) is ranked lower than
56% of the 311 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.93 vs. UNIS: -86.21 )
UNIS' s 10-Year ROA (%) Range
Min: -83.87   Max: -1.74
Current: -86.21

-83.87
-1.74
ROC (Joel Greenblatt) (%) -122.72
UNIS's ROC (Joel Greenblatt) (%) is ranked higher than
52% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.68 vs. UNIS: -122.72 )
UNIS' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -156.25   Max: -7.75
Current: -122.72

-156.25
-7.75
Revenue Growth (3Y)(%) 10.90
UNIS's Revenue Growth (3Y)(%) is ranked higher than
89% of the 263 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.60 vs. UNIS: 10.90 )
UNIS' s 10-Year Revenue Growth (3Y)(%) Range
Min: -50   Max: 76.5
Current: 10.9

-50
76.5
EBITDA Growth (3Y)(%) -8.80
UNIS's EBITDA Growth (3Y)(%) is ranked higher than
60% of the 234 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. UNIS: -8.80 )
UNIS' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -8.8   Max: 149.3
Current: -8.8

-8.8
149.3
EPS Growth (3Y)(%) -5.50
UNIS's EPS Growth (3Y)(%) is ranked higher than
63% of the 228 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.40 vs. UNIS: -5.50 )
UNIS' s 10-Year EPS Growth (3Y)(%) Range
Min: -5.5   Max: 239.1
Current: -5.5

-5.5
239.1
» UNIS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

UNIS Guru Trades in Q1 2014

Paul Tudor Jones Sold Out
Jim Simons Sold Out
» More
Q2 2014

UNIS Guru Trades in Q2 2014

Jim Simons 319,845 sh (New)
» More
Q3 2014

UNIS Guru Trades in Q3 2014

Jim Simons 277,940 sh (-13.10%)
» More
Q4 2014

UNIS Guru Trades in Q4 2014

Ron Baron 150,514 sh (New)
Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with UNIS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/S 27.20
UNIS's P/S is ranked lower than
79% of the 341 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.17 vs. UNIS: 27.20 )
UNIS' s 10-Year P/S Range
Min: 13.13   Max: 86.25
Current: 27.2

13.13
86.25
EV-to-EBIT -9.02
UNIS's EV-to-EBIT is ranked higher than
51% of the 341 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 35.16 vs. UNIS: -9.02 )
UNIS' s 10-Year EV-to-EBIT Range
Min: -19.6   Max: -3.2
Current: -9.02

-19.6
-3.2
Current Ratio 1.17
UNIS's Current Ratio is ranked higher than
50% of the 305 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.61 vs. UNIS: 1.17 )
UNIS' s 10-Year Current Ratio Range
Min: 0.69   Max: 8.01
Current: 1.17

0.69
8.01
Quick Ratio 1.16
UNIS's Quick Ratio is ranked higher than
60% of the 305 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.77 vs. UNIS: 1.16 )
UNIS' s 10-Year Quick Ratio Range
Min: 0.68   Max: 7.77
Current: 1.16

0.68
7.77
Days Sales Outstanding 104.05
UNIS's Days Sales Outstanding is ranked higher than
62% of the 341 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 70.73 vs. UNIS: 104.05 )
UNIS' s 10-Year Days Sales Outstanding Range
Min: 0.71   Max: 133.99
Current: 104.05

0.71
133.99

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.80
UNIS's Price/Median PS Value is ranked higher than
94% of the 341 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.40 vs. UNIS: 0.80 )
UNIS' s 10-Year Price/Median PS Value Range
Min: 0.36   Max: 2.1
Current: 0.8

0.36
2.1
Earnings Yield (Greenblatt) -11.60
UNIS's Earnings Yield (Greenblatt) is ranked lower than
52% of the 304 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.40 vs. UNIS: -11.60 )
UNIS' s 10-Year Earnings Yield (Greenblatt) Range
Min: -13.8   Max: 0
Current: -11.6

-13.8
0

Analyst Estimate

Jun15 Jun16
EPS($) -0.12 0.18
EPS without NRI($) -0.12 0.18

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:UNS.Australia, UNISZ.USA, 4UL.Germany,
Unilife Corporation Limited, formerly Unilife Medical Solutions Limited is an US-based medical device company focused on the design, development, manufacture and supply of a proprietary range of retractable syringes. Target customers include pharmaceutical manufacturers, suppliers of medical equipment, healthcare facilities and patients who self-administer prescription medication. Unilife is ISO 13485-certified and has FDA-registered medical device manufacturing facilities in Pennsylvania.
» More Articles for UNIS

Headlines

Articles On GuruFocus.com
Weekly CEO Buys Highlight: BH, TRCR, SHOR, IEC, UNIS Feb 11 2012 
Weekly CEO Buys Highlight: BH, TRCR, SHOR, IEC, UNIS Feb 11 2012 
Weekly CEO Buys Highlight: IDCC, MWW, UNIS Jan 29 2012 
Weekly CEO Buys Highlight: IDCC, MWW, UNIS Jan 29 2012 
Weekly CEO Buys Highlight: IDCC, MWW, UNIS Jan 29 2012 
Medical. All insider Jan 24 2012 
Weekly CEO Buys Highlight: TRNO, UNIS, GFN Jan 21 2012 
Weekly CEO Buys Highlight: UNIS, TRNO, WINA, SXC, CTFO Jan 15 2012 
3.31 Jan 12 2012 
Recent Purchase Jan 08 2012 

More From Other Websites
Unilife Appoints Dr. Richard Beckman as Chief Medical Officer Apr 08 2015
Unilife Appoints Dr. Richard Beckman as Chief Medical Officer Apr 08 2015
UNILIFE CORP Financials Feb 14 2015
UNILIFE CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Feb 12 2015
10-Q for Unilife Corp. Feb 11 2015
Six stocks to watch Feb 11 2015
Mid Session Options Activity Feb 11 2015
Notable option activity in equities Feb 11 2015
Unilife's unique delivery systems Feb 10 2015
Street Talk: RIG, EQR, CYBR, TPX & UNIS Feb 10 2015
Unilife reports 2Q loss Feb 09 2015
Unilife reports 2Q loss Feb 09 2015
UNILIFE CORP Files SEC form 10-Q, Quarterly Report Feb 09 2015
Unilife Corporation Announces Financial Results For Fiscal Year 2015 Second Quarter Feb 09 2015
Unilife Corp Earnings Call scheduled for 4:30 pm ET today Feb 09 2015
Unilife Corporation Announces Financial Results For Fiscal Year 2015 Second Quarter Feb 09 2015
Q2 2015 Unilife Corp Earnings Release - After Market Close Feb 09 2015
Unilife to Participate in the 2015 Leerink Global Healthcare Conference Feb 06 2015
Unilife to Participate in the 2015 Leerink Global Healthcare Conference Feb 06 2015
Unilife Announces Closing of Underwritten Offering of Common Stock and Full Exercise of the... Feb 04 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK